Fuller H B CO 10-Q quarterly reports

H.B. Fuller reports strong Q2 2026 revenue growth and announces a definitive agreement to acquire Advanced Medical Solutions Group plc.

H.B. Fuller Company reported a significant increase in net income and diluted EPS for Q1 2026, despite a slight decrease in net revenue, driven by improved gross profit margins and strategic acquisitions.

H.B. Fuller Company reported a 21.3% increase in net income and a 24.5% rise in diluted EPS for the third quarter of 2025, driven by improved gross profit margins and strategic acquisitions, despite a slight revenue decline.

H.B. Fuller Company announced a significant decrease in net income and diluted earnings per share for the second quarter and first six months of fiscal year 2025, primarily driven by negative currency effects, higher interest expense, and discrete tax charges, despite achieving positive organic revenue growth and improved gross profit margins.

H.B. Fuller's first quarter 2025 net income decreased significantly due to lower revenue and increased raw material and manufacturing expenses.

H.B. Fuller's Q3 2024 net income rose to $55.4 million, up from $37.6 million in Q3 2023, driven by acquisitions and increased sales volume.

H.B. Fuller's second quarter 2024 results show a revenue increase driven by acquisitions and volume growth, alongside improved profitability due to lower raw material costs.

H.B. Fuller's first quarter saw a slight revenue increase, driven by acquisitions, but was offset by pricing and volume declines, while gross profit margin improved due to lower raw material costs.